[Recent progress in therapy of inflammatory bowel diseases].
Kougo
Y
Y
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001379:Azathioprine / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000628:therapy*; D003424:Crohn Disease / Q000628:therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D004750:Enteral Nutrition; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage; D007937:Leukapheresis; D019804:Mesalamine / Q000008:administration & dosage; D008727:Methotrexate / Q000627:therapeutic use; D011965:Receptors, Glucocorticoid; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D011965:Receptors, Glucocorticoid; D013256:Steroids; D019804:Mesalamine; D016572:Cyclosporine; D001379:Azathioprine; D008727:Methotrexate